ATG5

protein-coding

autophagy related 5, the group of Autophagy related

Gene summary

The protein encoded by this gene, in combination with autophagy protein 12, functions as an E1-like activating enzyme in a ubiquitin-like conjugating system. The encoded protein is involved in several cellular processes, including autophagic vesicle formation, mitochondrial quality control after oxidative damage, negative regulation of the innate antiviral immune response, lymphocyte development and proliferation, MHC II antigen presentation, adipocyte differentiation, and apoptosis. Several transcript variants encoding different protein isoforms have been found for this gene. [provided by RefSeq, Sep 2015]

Previous symbols:
  • APG5L

MANE transcript

NM_004849.4

Inheritance

AR

ClinVar variants

U:17B:5

Top phenotype

ATG5-related disorder

gnomAD constraint

pLI —, LoF o/e 0.06

Max pathogenic AF

—

Genomic locus

chr6:106,045,423-106,325,791

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~280.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

spinocerebellar ataxia, autosomal recessive 25LIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0033115

Submitter: ClinGen

The relationship between the ATG5 gene and spinocerebellar ataxia, autosomal recessive 25 (SCAR25), was evaluated using the ClinGen Clinical Validity Framework as of July 13, 2022 and re-evaluated on October 23, 2025. ATG5 encodes autophagy 5 protein, a protein involved in cellular autophagy via binding the ATG12 protein (PMID: 9759731, PMID: 9852036) to form a complex needed for formation of the autophagic isolation membrane, which helps deliver cytoplasmic components to lysosomes for degradation in macroautophagy (PMID: 11266458). The lymphoblastoid cells of patients with biallelic ATG5 variants reported showed reduced levels of the ATG5-ATG12 protein complex and decreased autophagic flux, consistent with impaired autophagy due to impeded ATG5-ATG12 interaction (PMID: 26812546). The disease mechanism of SCAR25 is loss of function. SCAR25 was first reported in 2005 (PMID:15981765) and the first report of biallelic variants in ATG5 among patients with SCAR25 was in 2016 (PMID: 26812546). In this report, a homozygous missense variant, c.366A>T (p.E122D), was reported to segregate in a consanguineous Turkish family with two affected members; as noted above, lymphoblastoid cells of patients (who were homozygous for this ATG5 variant) showed reduced levels of the ATG5-ATG12 protein complex and decreased autophagic flux, supporting that the variant resulted in impaired autophagy due to impeded ATG5-ATG12 interaction (PMID: 26812546).To date, this first report (PMID: 26812546) appears to be the only report of biallelic ATG5 variants among patients with SCAR25. In addition to the case-level (genetic) evidence (4 points; including 2 points for the variant and 2 points for segregation), there is also experimental evidence supporting the relationship between SCAR25 and ATG5 (6 points total). Experimental evidence for the relationship between ATG5 and SCAR25 includes the biochemical function of the gene product (autophagy 5) being consistent with the reduced autophagic flux found in individuals with SCAR25 (PMID: 26812546), the biochemical and clinical features of a ATG5 knockout Drosophila model (PMID: 26812546), and rescue of a a ATG5 knockout Drosophila model via reexpression of a wild-type ATG5 transgene (PMID: 26812546). In summay, the relationship between ATG5 and SCAR25 is limited. While the total points awarded (10 points) would allow for the classificaiton of "moderate", only a single family with a homozygous single variant has been reported. Therefore, additional case-level evidence is needed to support a causal role. This clinical validity classification of limited was first approved by the ClinGen Lysosomal Diseases GCEP on July 21, 2022 (SOP v9), and re-evaluated by the ClinGen General IEM GCEP on October 24, 2025 (SOP v11).

spinocerebellar ataxia, autosomal recessive 25LIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0033115

Submitter: Labcorp Genetics (formerly Invitae)

spinocerebellar ataxia, autosomal recessive 25LIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0033115

Submitter: Ambry Genetics

spinocerebellar ataxia, autosomal recessive 25MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0033115

Submitter: PanelApp Australia

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ATG5 variants in ClinVar

4 Conditions Cataloged
not specifiedTotal: 13
not providedTotal: 5
ATG5-related disorderTotal: 2
Spinocerebellar ataxia, autosomal recessive 25Total: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_004849.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
2
clinvar
3
missense
13
clinvar
1
clinvar
2
clinvar
16
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
3
clinvar
3
Total00171422
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 60 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_004849.4RefSeqNP_004840.17MANE Select
ENST00000369076.8EnsemblENSP00000358072.37MANE Select
NM_001286106.2RefSeqNP_001273035.17Standard
NM_001286107.2RefSeqNP_001273036.16Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
atg5Danio rerio

Structure: dopaminergic neuron

Quality: decreased amount

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Longevity regulating pathway - multiple species - Homo sapiens (human)
  • Autophagy - animal - Homo sapiens (human)
  • Autophagy - other - Homo sapiens (human)
  • Mitophagy - animal - Homo sapiens (human)
  • Longevity regulating pathway - Homo sapiens (human)

Biological Process

  • autophagosome assembly
  • autophagy of mitochondrion
  • blood vessel remodeling
  • regulation of cytokine secretion involved in immune response
  • C-terminal protein lipidation

Molecular Function

  • protein binding
  • Atg8 ligase activity

Cellular Component

  • cytoplasm
  • autophagosome
  • cytosol
  • axoneme
  • membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000369076
Coding exons
7
Length
141316
Individuals with no LoFs
125630
Homozygous LoFs
0
Heterozygous LoFs
2
Defined
125632
p
0.00000796
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.82811420.5700.000006891842
Missense (PolyPhen)2152.4250.40057681
Synonymous0.8913845.70.8320.00000228475
Loss of Function3.48116.10.06238.24e-7194

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000370.000029rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.00000880.0000088rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Involved in autophagic vesicle formation. Conjugation with ATG12, through a ubiquitin-like conjugating system involving ATG7 as an E1-like activating enzyme and ATG10 as an E2-like conjugating enzyme, is essential for its function. The ATG12-ATG5 conjugate acts as an E3-like enzyme which is required for lipidation of ATG8 family proteins and their association to the vesicle membranes. Involved in mitochondrial quality control after oxidative damage, and in subsequent cellular longevity. Plays a critical role in multiple aspects of lymphocyte development and is essential for both B and T lymphocyte survival and proliferation. Required for optimal processing and presentation of antigens for MHC II. Involved in the maintenance of axon morphology and membrane structures, as well as in normal adipocyte differentiation. Promotes primary ciliogenesis through removal of OFD1 from centriolar satellites and degradation of IFT20 via the autophagic pathway. {ECO:0000250|UniProtKB:Q99J83, ECO:0000269|PubMed:12207896, ECO:0000269|PubMed:20580051, ECO:0000269|PubMed:22170153, ECO:0000269|PubMed:26812546}.; FUNCTION: (Microbial infection) May act as a proviral factor. In association with ATG12, negatively regulates the innate antiviral immune response by impairing the type I IFN production pathway upon vesicular stomatitis virus (VSV) infection (PubMed:17709747). Required for the translation of incoming hepatitis C virus (HCV) RNA and, thereby, for initiation of HCV replication, but not required once infection is established (PubMed:19666601). {ECO:0000269|PubMed:17709747, ECO:0000269|PubMed:19666601}.;
Disease
DISEASE: Spinocerebellar ataxia, autosomal recessive, 25 (SCAR25) [MIM:617584]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR25 patients manifest delayed psychomotor development with delayed walking, truncal ataxia, dysmetria, and nystagmus, Cerebellar hypoplasia is seen on brain imaging. {ECO:0000269|PubMed:26812546}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.171

Intolerance Scores

LoFtool
0.0998
RVIS EVS
0.1
RVIS percentile EVS
61.28

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.741

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.